Eur Rev Med Pharmacol Sci 2020; 24 (7): 4030-4034

DOI: 10.26355/eurrev_202004_20873

An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections

A. Ahmad, M.U. Rehman, K.M. Alkharfy

Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. alkharfy@ksu.edu.sa


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain that was discovered in 2019 and has not been previously identified in humans. On December 31st 2019 World Health Organization (WHO) was informed of a cluster of cases with pneumonia of unknown origin from Wuhan City, Hubei province of China. The WHO announced in February 2020 that COVID-19 is the official name of the coronavirus diseases. A total of 519,899 confirmed cases with 23,592 deaths linked to this pathogen as on March 27, 2020 have been reported. Due to increasing number of infected people across the continents and huge loss to human life, the WHO has declared the novel COVID-19 outbreak a pandemic. A pandemic is defined as the “worldwide spread” of a new disease. Currently, no COVID-19 specific treatments have been approved by the United States Food and Drug Administration (US-FDA). However, the current treatment options include hydroxychloroquine, tocilizumab, remdesivir, lopinavir-ritonavir (Kaletra®), and nitazoxanide. In recent past, some natural herbal compounds have demonstrated encouraging anti-viral properties. This article attempted to summarize available information on the reported anti-viral activity of some natural products.

Free PDF Download

To cite this article

A. Ahmad, M.U. Rehman, K.M. Alkharfy
An alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 7
Pages: 4030-4034
DOI: 10.26355/eurrev_202004_20873